Fusion Antibodies PLC Working Capital to Net Assets Ratio
Fusion Antibodies PLC working capital to net assets ratio. Fusion Antibodies PLC (FAB) has a Working Capital to Net Assets ratio of 85.4% as of September 2025. Working capital of GBX620.00K (current assets of GBX1.39 Million minus current liabilities of GBX772.00K) is measured against net assets of GBX726.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Fusion Antibodies PLC (FAB) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Fusion Antibodies PLC (2013–2025)
Working capital to net assets ratio of Fusion Antibodies PLC from 2013 to 2025. This chart shows how Fusion Antibodies PLC's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of September 2025, the ratio stands at 85.4%, reflecting working capital of GBX620.00K against net assets of GBX726.00K GBX. See Fusion Antibodies PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Fusion Antibodies PLC Working Capital to Net Assets Ratio by Year (2013–2025)
Fusion Antibodies PLC working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Fusion Antibodies PLC from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Fusion Antibodies PLC.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 95.2% | GBX637.00K | GBX669.00K | GBX1.26 Million | GBX623.00K | ▲ +1.6 pp |
| 2024 | 93.6% | GBX1.68 Million | GBX1.79 Million | GBX2.26 Million | GBX584.00K | ▲ +21.6 pp |
| 2023 | 72.0% | GBX808.00K | GBX1.12 Million | GBX1.69 Million | GBX879.00K | ▼ -11.5 pp |
| 2022 | 83.4% | GBX3.07 Million | GBX3.68 Million | GBX4.28 Million | GBX1.21 Million | ▲ +5.3 pp |
| 2021 | 78.1% | GBX3.71 Million | GBX4.75 Million | GBX4.71 Million | GBX996.00K | ▲ +40.5 pp |
| 2020 | 37.7% | GBX1.81 Million | GBX4.81 Million | GBX2.80 Million | GBX989.00K | ▼ -9.2 pp |
| 2019 | 46.9% | GBX2.51 Million | GBX5.35 Million | GBX3.31 Million | GBX795.90K | ▼ -28.2 pp |
| 2018 | 75.1% | GBX4.94 Million | GBX6.58 Million | GBX5.51 Million | GBX570.06K | ▲ +45.8 pp |
| 2017 | 29.3% | GBX499.81K | GBX1.71 Million | GBX930.02K | GBX430.22K | ▲ +8.7 pp |
| 2016 | 20.6% | GBX300.14K | GBX1.46 Million | GBX691.57K | GBX391.43K | ▼ -69.7 pp |
| 2015 | 90.3% | GBX152.85K | GBX169.29K | GBX334.51K | GBX181.67K | ▲ +264.1 pp |
| 2014 | -173.8% | GBX-28.36K | GBX16.32K | GBX269.20K | GBX297.57K | ▼ -163.3 pp |
| 2013 | -10.5% | GBX-5.28K | GBX50.13K | GBX248.28K | GBX253.56K | — |